Quantum Resonance logo Quantum Resonance Advanced Bio-Acoustic Labs
Email Us Request Dossier

Evidence & Safety / Research Context

Bio-Photonic Therapy

What's been published under the term "bio-photonic therapy," and what it does and doesn't tell you about the Aura Matrix Elite.

Vibroacoustic & Thermography Far Infrared Near Infrared TENS Bio-Photonic

"Bio-photonic" is a broad, loosely defined term. It's used for at least two very different things in the published literature: (1) conventional light-based therapies delivered by specific commercial devices, tested in real randomized trials, and (2) a much less established idea that the body itself emits and can be influenced by "biophotons," which has far thinner and lower-quality support. None of the research below was conducted on the Aura Matrix Elite. It's included as general background on the term, not as clinical evidence for this device — and we've separated the two categories below so the difference in evidence quality is clear.

Clinical Light Therapy Sold as "Bio-Photonic"

The most clinically tested use of this term belongs to a specific commercial system, Kleresca (KLOX Technologies), which pairs a topical gel with an LED lamp to produce what the manufacturer calls "fluorescent light energy" (FLE) — a form of photobiomodulation. This is a proprietary, patented product with its own published trials; it is not a general description of any light-emitting device.

A randomized, placebo-controlled, split-face trial (Nikolis et al., 2016) tested the KLOX-001 gel-and-LED combination for facial skin rejuvenation. A separate postmarket study of nine patients found FLE reduced facial redness and improved patient-reported symptoms of rosacea over four weekly sessions. Sources: study summary in link.springer.com/chapter/10.1007/978-3-030-45351-0_37; rosacea study: jcadonline.com/biophotonic-fluorescent-light-rosacea.

This research is specific to that gel-plus-LED system, tested for specific dermatologic conditions (rosacea, skin rejuvenation, and in other published work, acne). It doesn't generalize to light delivered without the accompanying photosensitizing gel, or to a different device or wavelength.

"Biophoton Emission" Research — Much Less Established

A separate, older line of research concerns "ultra-weak photon emission" — the idea that living cells and tissue naturally emit extremely faint light, and that this emission can be measured or influenced. A 2023 patent filing describes lab measurements of this emission in skin samples treated with a light-activated gel. This is a real, measurable physical phenomenon studied in biophysics, but it is a different subject from clinical treatment outcomes.

Some small clinical studies extend this idea further. One 2025 conference abstract described a triple-blinded, placebo-controlled trial of 30 Alzheimer's patients using a "biophoton generator" device, reporting improvements in cognition and a proprietary "bioenergy" measurement. We're flagging this study specifically because of its limitations: it was published as a conference abstract rather than a full peer-reviewed paper, involved a single author, used a non-standard "bioenergy scanner" outcome measure that isn't independently validated, and had a very small sample size. This is a preliminary, unreplicated finding — not established evidence.

A broader, non-peer-reviewed preprint has also proposed "biophotonic" ultraviolet exposure as an antimicrobial and antiviral treatment approach; because it is explicitly labeled not peer-reviewed by its own publisher, we aren't treating it as evidence of anything here.

What This Does Not Tell You

None of the studies above were conducted on the Aura Matrix Elite, its phototherapy array, or the Aura Video Station 7's readings — including the "bio-energetic reserve" figures referenced elsewhere on this site, which are a proprietary reading from that third-party biofeedback device, not a measurement validated by any of the research above. The clinical trials in this field belong to a specific, different commercial product (Kleresca) using a specific gel-and-light combination; the "biophoton emission" research is a distinct, far less established area with limited human trial data.

It's included here because "bio-photonic" is a term used across this range of research quality — not because any of it demonstrates anything about this product's effects on any specific person.

Back to Evidence & Safety. Questions about this research or our hardware: shin@auramatrix.net.